Lycia Therapeutics, Inc.: amends charter and bylaws

What happened Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation (the “Charter”) with the Secretary of State of the State of Delaware, and its Amended and Restated Bylaws (the “Bylaws”) became effective on Oct 26, 2026 in connection with the closing of the initial public offering (the “Offering”) of shares of the company’s common stock, par value $0.0001 per share. The filing notes that, as described in the final prospectus dated Oct 22, 2026 relating to the Registration Statement on Form S-1 (File No. 333-299300), the board of directors and stockholders previously approved the amendment and restatement to be effective immediately prior to the closing of the Offering.

Key details

• Charter and bylaws became effective Oct 26, 2026 in connection with closing of the company’s initial public offering.
• Final prospectus dated Oct 22, 2026; Registration Statement on Form S-1, File No. 333-299300.
• Common stock par value is $0.0001 per share.
• The board of directors and stockholders had approved the amendment and restatement to be effective immediately prior to the Offering’s closing.

Why it may matter This Form 8-K reports Item 5.03: Amendments to articles of incorporation or bylaws, which covers the filing of an amended and restated certificate of incorporation and the adoption of amended and restated bylaws effective Oct 26, 2026 in connection with the closing of the initial public offering. This filing does not show why the insider traded or why the company acted.